Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Duarte, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Maywood, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
Rochester, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Columbus, Ohio, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 30 Sept 2008
- Completion
- 31 Mar 2015
- Last update posted
- 30 Jan 2017
- Registered enrollment
- 134
- Registry id
- NCT00358501
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.